Listed

Spero Therapeutics, Inc.

SPRONasdaqCIK 1701108HealthcareFiscal year ends Dec 31

Reports and events: 174 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Spero Therapeutics, Inc., Reports and events
FiledFormWhat it isAccession number
2018-09-2716:08 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-18-285631
2018-08-1408:09 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-18-247901
2018-08-0916:21 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-18-244366
2018-08-0916:01 ET10-QQuarterly reportPeriod 2018-06-300001564590-18-021018
2018-07-1716:31 ET8-K5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001193125-18-219722
2018-07-1607:13 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-18-218281
2018-07-1117:30 ETS-1/ARegistration statement, amended0001193125-18-216210
2018-07-0916:21 ET8-K2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-18-214735
2018-07-0916:05 ETS-1Registration statement0001193125-18-214717
2018-07-0907:38 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-18-214220
2018-06-0816:01 ET8-K5.07 Shareholder vote results0001193125-18-188029
2018-05-1016:13 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-18-159225
2018-05-1016:03 ET10-QQuarterly reportPeriod 2018-03-310001564590-18-012933
2018-04-2708:20 ETDEF 14AProxy statementPeriod 2018-06-050001193125-18-136751
2018-04-0217:11 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-18-104993
2018-04-0216:02 ET10-KAnnual reportPeriod 2017-12-310001564590-18-007402
2018-03-1416:30 ETSC 13DOwnership report, active investor0001144204-18-014661
2018-02-0108:30 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-18-028379
2018-01-2308:00 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001193125-18-016749
2017-12-1416:25 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-17-369517
2017-12-1416:03 ET10-QQuarterly reportPeriod 2017-09-300001193125-17-369457
2017-11-0616:23 ET8-K5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-17-334318
2017-10-2310:31 ETS-1/ARegistration statement, amended0001193125-17-315961
2017-10-0616:13 ETS-1Registration statement0001193125-17-305888

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 13, 2026, 16:27 ET. Listed shows no prices and gives no investment advice.